Recursion Pharmaceuticals, Inc. is advancing REC-1245, an RBM39 degrader, in the DHALIA trial in solid tumors. Read more on ...
Just as with LLMs, success in other frontiers of AI will require access to large volumes of high-quality data. That will ...
Many founders are missing the moment.
Signals are not primarily an event system, and they are not designed to replace RxJS. They represent a different way of ...
The news is a clean AI/data-center chip growth stack: Q1 revenue +28%, management calling for accelerating Q2, full-year ...
FDA revised guidance documents for low-risk wellness products and clinical decision software, clarifying regulatory ...
Rust will save Linux from AI, says Greg Kroah-Hartman ...
The medical device analyzes patient cancer risk without them needed to do any additional tests or imaging.
Targeted protein degradation (TPD) therapeutics seek to harness this intrinsic quality control machinery to selectively ...
As industry shifts to continuous biomanufacturing, engineers integrate process design, digital tools, automation, and ...
Every few years, a wildfire resets the terms of the conversation. The January 2025 fires that swept through Los Angeles did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results